-
Company Profile
Organogenesis Holdings Inc – Company Profile
Organogenesis Holdings Inc (Organogenesis) is a regenerative medicine company that develops, manufactures and commercialization of solutions for advanced wound care, surgical and sports medicine. The company’s product portfolio includes dermagraft, nushield, apligraf, affinity, fiberos, OCMP, puraforce and puraply. Its dermagraft is used for the treatment of diabetic foot ulcers. Organogenesis’s apligraf is used for the treatment of venous leg ulcers and diabetic foot ulcers. The company products treat in area orthopedic and neurosurgical such as spinal fusions and foot and...
Add to Basket -
Product Insights
Tissue Engineered – Skin Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Tissue engineering for wound care management is the use of mechanical and chemical processing of materials to manufacture products that may substitute or replace all or some components that make up normal skin (e.g., epidermis and/or dermis, cells, and matrix). The tissue engineered - skin substitutes pipeline market research report provides comprehensive information about the tissue engineered - skin substitutes pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials...